In the BioHarmony Drug Report Database

"Preview" Icon

Acetylcysteine

Acetadote, Cetylev, Mucomyst (acetylcysteine) is a small molecule pharmaceutical. Acetylcysteine was first approved as Acetadote on 1982-01-01. It is used to treat amyloidosis, bronchiectasis, bronchitis, cystic fibrosis, and pneumonia amongst others in the USA. Acetylcysteine’s patents are valid until 2032-05-08 (FDA).

 

Trade Name

 

Acetadote, Cetylev, Mucomyst
 

Common Name

 

acetylcysteine
 

ChEMBL ID

 

CHEMBL600
 

Indication

 

amyloidosis, bronchiectasis, bronchitis, cystic fibrosis, pneumonia, poisoning, pulmonary emphysema, respiratory distress syndrome
 

Drug Class

 

Image (chem structure or protein)

Acetylcysteine structure rendering